Visfatin levels have been reported to be increased in MS patients compared to healthy individuals [59], particularly in those with RRMS, and these levels show a positive correlation with TNF-α and a negative correlation with FoxP3 mRNA in T cells [60]. The gene discussed is NAMPT; the disease is myeloid sarcoma.